Literature DB >> 23884488

Reduction of facial redness with resveratrol added to topical product containing green tea polyphenols and caffeine.

Georgina Ferzli1, Mital Patel, Natasha Phrsai, Neil Brody.   

Abstract

BACKGROUND/
OBJECTIVE: Many topical formulations include antioxidants to improve the antioxidant capability of the skin. This study evaluated the ability of a unique combination of antioxidants including resveratrol, green tea polyphenols, and caffeine to reduce facial redness.
METHODS: Subjects (n=16) presenting with facial redness applied the resveratrol-enriched product twice daily to the entire face. Reduction in redness was evaluated by trained staff members and dermatology house staff officers. Evaluators compared clinical photographs and spectrally enhanced images taken before treatment and at 2-week intervals for up to 12 weeks.
RESULTS: 16 of 16 clinical images showed improvement and 13 of 16 spectrally enhanced images were improved. Reduction in facial redness continued to evolve over the duration of the study period but was generally detectable by 6 weeks of treatment. Adverse effects were not observed in any subject.
CONCLUSION: The skin product combination of resveratrol, green tea polyphenols, and caffeine safely reduces facial redness in most patients by 6 weeks of continuous treatment and may provide further improvement with additional treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884488

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

Review 1.  Grapevine Wastes: A Rich Source of Antioxidants and Other Biologically Active Compounds.

Authors:  Anda Maria Baroi; Mircea Popitiu; Irina Fierascu; Ionela-Daniela Sărdărescu; Radu Claudiu Fierascu
Journal:  Antioxidants (Basel)       Date:  2022-02-15

2.  Relationship Between Tea Drinking Behaviour and Rosacea: A Clinical Case-control Study.

Authors:  Ben Wang; Bingbing Yan; Zhixiang Zhao; Yan Tang; Ying-Xue Huang; Dan Jian; Wei Shi; Hongfu Xie; Yaling Wang; Ji Li
Journal:  Acta Derm Venereol       Date:  2021-06-30       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.